
Sign up to save your podcasts
Or
Full article: https://www.ajronline.org/doi/10.2214/AJR.22.28385
Locoregional therapies for hepatocellular carcinoma perform differently when compared by rates of complete pathologic necrosis of lesions. Juliet Alla, MD discusses a new AJR study that demonstrates improved rates of complete pathologic necrosis for patients with HCC who underwent thermal ablation and TARE therapies, when compared to those who received TACE. Special guest Dr. Zachary Berman, an interventional radiologist who specializes in locoregional therapies for hepatocellular carcinoma, joins to discuss the implications for clinical practice.
4.5
4343 ratings
Full article: https://www.ajronline.org/doi/10.2214/AJR.22.28385
Locoregional therapies for hepatocellular carcinoma perform differently when compared by rates of complete pathologic necrosis of lesions. Juliet Alla, MD discusses a new AJR study that demonstrates improved rates of complete pathologic necrosis for patients with HCC who underwent thermal ablation and TARE therapies, when compared to those who received TACE. Special guest Dr. Zachary Berman, an interventional radiologist who specializes in locoregional therapies for hepatocellular carcinoma, joins to discuss the implications for clinical practice.
11,185 Listeners
3,176 Listeners
88 Listeners
27 Listeners
21,892 Listeners
494 Listeners
43,359 Listeners
2,424 Listeners
29 Listeners
8,004 Listeners
135 Listeners
26,938 Listeners
218 Listeners
205 Listeners
28,602 Listeners